A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience
Condition: Healthy Volunteers Interventions: Drug: Soticlestat 300 mg; Drug: Soticlestat 600 mg; Drug: Soticlestat 900 mg; Drug: Alprazolam; Drug: Placebo Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2022 Category: Research Source Type: clinical trials